NATIONALUM.NS(NATIONALUM.NS)
NATIONALUM.NS
$361.00—Stale · unknown old
NSE • Last print unknown ago
$361.00—Stale · unknown old
No analyst ratings available
No analyst price targets available for NATIONALUM.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $206.94B | $219.73B | $234.43B |
| Low | $191.39B | $196.04B | $222.18B |
| High | $219.29B | $257.73B | $257.80B |
| EBITDA Avg | $103.92B | $108.03B | $121.01B |
| Low | $88.08B | $95.22B | $105.18B |
| High | $123.20B | $134.36B | $150.93B |
| EBIT Avg | $93.77B | $95.51B | $106.29B |
| Low | $77.93B | $82.69B | $90.46B |
| High | $113.05B | $121.84B | $136.21B |
| Net Income Avg | $69.97B | $71.28B | $79.36B |
| Low | $58.09B | $61.67B | $67.49B |
| High | $84.43B | $91.02B | $101.80B |
| EPS Avg | $40.17 | $41.59 | $43.68 |
| Low | $31.63 | $33.57 | $36.74 |
| High | $45.96 | $49.55 | $55.42 |
| Analysts (Rev / EPS) | 12 / 10 | 13 / 11 | 6 / 5 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $49.20B | $50.27B | $57.51B |
| Low | $47.21B | $48.65B | $55.42B |
| High | $51.19B | $51.89B | $59.60B |
| EBITDA Avg | $49.67B | $26.13B | $26.32B |
| Low | $47.44B | $25.02B | $25.20B |
| High | $51.91B | $27.25B | $27.43B |
| EBIT Avg | $47.70B | $24.00B | $24.00B |
| Low | $45.46B | $22.88B | $22.88B |
| High | $49.93B | $25.12B | $25.12B |
| Net Income Avg | $35.53B | $17.77B | $17.77B |
| Low | $33.86B | $16.93B | $16.93B |
| High | $37.21B | $18.61B | $18.61B |
| EPS Avg | $19.35 | $9.67 | $9.67 |
| Low | $18.43 | $9.22 | $9.22 |
| High | $20.26 | $10.13 | $10.13 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 |